364 results on '"Seydi, Moussa"'
Search Results
2. Accuracy of PHQ-9 against psychiatric diagnosis for depression among people living with HIV: A multicounty cross-sectional study
3. Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial
4. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study
5. Systematic review and individual-patient-data meta-analysis of non-invasive fibrosis markers for chronic hepatitis B in Africa
6. Linear epitope mapping of the humoral response against SARS-CoV-2 in two independent African cohorts
7. Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study
8. Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial)
9. Efficacy and safety of three antiretroviral therapy regimens for treatment-naive African adults living with HIV-2 (FIT-2): a pilot, phase 2, non-comparative, open-label, randomised controlled trial
10. Cost-utility analysis of four WHO-recommended sofosbuvir-based regimens for the treatment of chronic hepatitis C in sub-Saharan Africa
11. Accuracy of nine-item Patient Health Questionnaire against psychiatric diagnosis for depression among people with HIV.
12. Severe dengue in adults and children, Ouagadougou (Burkina Faso), West Africa, October 2015–January 2017
13. Service delivery challenges in HIV care during the first year of the COVID‐19 pandemic: results from a site assessment survey across the global IeDEA consortium
14. Effects of the COVID-19 Pandemic on ART Initiation and Access to HIV Viral Load Monitoring in Adults Living With HIV in West Africa: A Regression Discontinuity Analysis.
15. Antiviral Activity of Lenacapavir Against Human Immunodeficiency Virus Type 2 (HIV-2) Isolates and Drug-Resistant HIV-2 Mutants.
16. Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
17. Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in adults in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial
18. Faible indice de masse corporelle et impact des antirétroviraux sur la néphrotoxicité, la maladie rénale chronique chez les patients infectés par le VIH à Brazzaville, Congo
19. Perceptions, facilitators and barriers to the implementation of interpersonal group therapy to treat depression among people living with HIV in Senegal: a qualitative study
20. Antiviral Activity of Lenacapavir Against HIV-2 Isolates and Drug-resistant HIV-2 Mutants
21. Severe Malaria and Risk Factors for Death in the Infectious Diseases Department of the University Hospital of Fann in Dakar, Senegal
22. A Model of the 2014 Ebola Epidemic in West Africa with Contact Tracing
23. Epidemiological, Clinical and Radiological Profile of Patients Hospitalized for COVID-19 at the Epidemic Treatment Centre of the Fann Hospital, Dakar during the Third and Fourth Waves
24. Feasability and effectiveness of scaling up hepatitis-C treatment in West and Central Africa: the TAC ANRS 12311 clinical trial
25. A Trial of a Single-tablet Regimen of Elvitegravir, Cobicistat, Emtricitabine, and Tenofovir Disoproxil Fumarate for the Initial Treatment of Human Immunodeficiency Virus Type 2 Infection in a Resource-limited Setting : 48-Week Results From Senegal, West Africa
26. Resource and infrastructure challenges on the RESIST-2 Trial: an implementation study of drug resistance genotype-based algorithmic ART switches in HIV-2-infected adults in Senegal
27. The impact of food insecurity on HIV outcomes in Senegal, West Africa: a prospective longitudinal study
28. Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study
29. Characteristics, Management, and Outcomes of Bacterial Dermohypodermatitis at the Infectious and Tropical Diseases Department of Fann University Hospital, 2016-2020
30. Metabolic and Immune Consequences of Antibiotic Related Microbiome Alterations during first-line Tuberculosis Treatment in Bamako, Mali
31. High prevalence of binge drinking among people living with HIV in four African countries
32. Rapport du groupe de travail sur les cahiers de laboratoires électroniques
33. COVID-19 Outbreak, Senegal, 2020
34. Detection and differentiation of HIV-2 using the point-of-care Alere q HIV-1/2 Detect nucleic acid test
35. Tetanus in the Elderly in Dakar: Epidemiological, Clinical, Evolutionary Aspects and Associated Factors of Death
36. Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workers
37. Simple treatment eligibility score for chronic HBV infection at peripheral health facilities in sub-Saharan Africa
38. Driving improvements in hepatitis B care in Africa: profile of the hepatitis B in Africa collaborative network (HEPSANET)
39. Clinical validation of a novel diagnostic HIV-2 total nucleic acid qualitative assay using the Abbott m2000 platform: Implications for complementary HIV-2 nucleic acid testing for the CDC 4th generation HIV diagnostic testing algorithm
40. Traditional healers, HIV outcomes, and mortality among people living with HIV in Senegal, West Africa
41. Prevalence, predictors, and management of advanced HIV disease among individuals initiating ART in Senegal, West Africa
42. Neuro-meningeal Tuberculosis in Adult Senegalese Patients: Profile and Outcome of Cases Diagnosed at a Referral Service, from 2015 to 2020
43. Risk Factors for COVID-19 Related Death during the First Three Waves of the Pandemic in an Epidemic Treatment Center at Dakar, Senegal
44. Factors associated with verbal fluency in older adults living with HIV in West Africa: A longitudinal study
45. Hepatitis B in Senegal: A Successful Infant Vaccination Program but Urgent Need to Scale Up Screening and Treatment (ANRS 12356 AmBASS survey)
46. Chronic viral hepatitis, <scp>HIV</scp> infection and <scp>Non‐Hodgkin</scp> lymphomas in West Africa, a case‐control study
47. Facteurs associés à la dissociation immunovirologique chez les patients infectés par le VIH-1 sous traitement antirétroviral hautement actif au Centre de Traitement Ambulatoire (CTA) de Dakar
48. Prevalence and Predictors of Liver Fibrosis in People Living with Hepatitis B in Senegal
49. Diagnostic performance of non-invasive liver fibrosis biomarkers: a bayesian individual patient data meta-analysis of hepatitis B cohorts in sub-saharan Africa (HEPSANET)
50. Diagnosis and clinical outcomes of extrapulmonary tuberculosis in antiretroviral therapy programmes in low‐ and middle‐income countries: a multicohort study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.